PUBLISHER: The Business Research Company | PRODUCT CODE: 2082357
PUBLISHER: The Business Research Company | PRODUCT CODE: 2082357
Thermoplastic elastomers in medical devices are rubber-like polymer materials that combine elasticity with the capability to be melted and reshaped like plastics, making them highly appropriate for medical manufacturing applications. They offer flexibility, softness, and durability while remaining biocompatible and compatible with standard sterilization methods. Thermoplastic elastomers are extensively utilized in medical devices including catheters, tubing, syringe components, seals, and wearable medical equipment.
The primary types of thermoplastic elastomers in medical devices include styrenic block copolymers, thermoplastic polyurethane, thermoplastic polyolefins, thermoplastic vulcanizates, and copolyester elastomers. Styrenic block copolymers refer to flexible and processable elastomeric materials extensively used in medical applications for their balance of elasticity and thermoplastic properties. These are processed through injection molding-grade thermoplastic elastomer, extrusion-grade thermoplastic elastomer, blow molding-grade thermoplastic elastomer, and overmolding and co-injection grade thermoplastic elastomer. The various applications involved are catheters and tubing, seals and gaskets, wearable medical devices, medical packaging, surgical instruments, and drug delivery systems, and they are used by several end users such as hospitals and clinics, ambulatory surgical centers, diagnostic laboratories, and home healthcare.
Tariffs are impacting the thermoplastic elastomers in medical devices market by raising the cost of imported specialty polymers, additives, medical-grade elastomer compounds, and precision molding equipment required for healthcare device manufacturing. This is slowing down production efficiency and increasing procurement costs for applications such as catheters and tubing, wearable medical devices, drug delivery systems, and medical packaging, particularly in regions dependent on imports such as Asia-Pacific and Europe. Material-intensive segments including thermoplastic polyurethane, styrenic block copolymers, and copolyester elastomers are most affected due to global supply chain dependencies. However, tariffs are also encouraging local manufacturing expansion, regional supplier diversification, and greater investment in domestic medical polymer production ecosystems, creating long-term resilience in the market.
The thermoplastic elastomers in medical devices market research report is one of a series of new reports from The Business Research Company that provides thermoplastic elastomers in medical devices market statistics, including thermoplastic elastomers in medical devices industry global market size, regional shares, competitors with a thermoplastic elastomers in medical devices market share, detailed thermoplastic elastomers in medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the thermoplastic elastomers in medical devices industry. This thermoplastic elastomers in medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The thermoplastic elastomers in medical devices market size has grown strongly in recent years. It will grow from $2.96 billion in 2025 to $3.15 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising demand for flexible catheter and tubing materials, increasing replacement of PVC with biocompatible elastomers, growth in minimally invasive surgical procedures, expansion of medical device manufacturing activities, increasing adoption of wearable healthcare devices.
The thermoplastic elastomers in medical devices market size is expected to see strong growth in the next few years. It will grow to $4.07 billion by 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to growing investment in sustainable medical polymers, rising demand for smart and connected wearable medical devices, increasing use of advanced overmolding and co-injection technologies, expansion of home healthcare and remote patient monitoring, growing innovation in high performance medical grade thermoplastic elastomers. Major trends in the forecast period include increasing demand for biocompatible and sterilization-compatible thermoplastic elastomers in medical devices, rising adoption of soft-touch thermoplastic elastomers for wearable medical equipment, growing use of recyclable and latex-free elastomer materials in healthcare manufacturing, expanding integration of antimicrobial thermoplastic elastomers in medical components, increasing development of lightweight and flexible thermoplastic elastomers for minimally invasive medical devices.
The rising adoption of minimally invasive aesthetic procedures is expected to propel the growth of the thermoplastic elastomers (TPE) market in medical devices. Minimally invasive aesthetic procedures, including dermal fillers, botulinum toxin injections, and laser-based treatments, are increasingly preferred because they provide cosmetic enhancements with minimal downtime, reduced discomfort, and lower risk compared to surgical alternatives. These procedures commonly depend on advanced delivery systems, such as syringes, catheters, and flexible tubing, where material performance is highly important. Thermoplastic elastomers play a significant role in supporting these applications by offering flexibility, soft-touch properties, biocompatibility, and chemical resistance, ensuring precision, safety, and patient comfort during procedures. For instance, in July 2024, according to the American Society Of Plastic Surgeons, minimally invasive aesthetic procedures increased by 5%, reaching 25.35 million treatments in 2024 compared to 24.11 million in 2023. Therefore, the rising adoption of minimally invasive devices is driving the growth of the thermoplastic elastomers in medical devices market.
Leading companies operating in the thermoplastic elastomers in medical devices market are emphasizing technological advancement in polymer engineering, such as bio-based elastomer formulation, to achieve a competitive advantage. Bio-based elastomer formulation involves incorporating renewable, plant-derived raw materials into the molecular structure of polymers to lower carbon footprints while maintaining medical-grade performance. For instance, in January 2024, Avient Corporation introduced versaflex hc bio bt218. This specialized grade includes bio-based content derived from plant resources, delivers excellent kink resistance for biopharmaceutical tubing, and maintains low extractable levels to protect sensitive fluids. These innovations enhance environmental sustainability and ensure patient safety during critical medical procedures. Therefore, technological advancements in the thermoplastic elastomers in medical devices market continue to drive high-performance healthcare solutions.
In July 2023, Arkema acquired Polytec PT for an undisclosed amount. Through this acquisition, Arkema seeks to expand its portfolio of high-performance thermoplastic elastomers and strengthen its position in advanced medical and healthcare applications by integrating specialized compounding capabilities. Polytec PT is a Germany-based provider of high-performance polymer compounds, including thermoplastic elastomers and engineering plastics tailored for medical devices, healthcare components, and regulated applications.
Major companies operating in the thermoplastic elastomers in medical devices market are BASF SE, Dow Inc., Asahi Kasei Corporation, Sibur Holding, Covestro AG, Mitsui Chemicals Inc., DSM-Firmenich, Celanese Corporation, Arkema S. A., Lubrizol Corporation, Kuraray Co. Ltd., Avient Corporation, Hexpol TPE AB, Kraton Corporation, Teknor Apex Company, RTP Company, Kraiburg TPE GmbH & Co. KG, Dynasol Group, Elastron TPE, LCY Chemical Corp.
North America was the largest region in the thermoplastic elastomers in medical devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thermoplastic elastomers in medical devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the thermoplastic elastomers in medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The thermoplastic elastomers in medical devices market consists of sales of styrene block copolymers, thermoplastic polyurethanes, thermoplastic polyolefins, thermoplastic vulcanizates, and copolyester elastomers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Thermoplastic Elastomers In Medical Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses thermoplastic elastomers in medical devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for thermoplastic elastomers in medical devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The thermoplastic elastomers in medical devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.